Josh Bilenker – Biography
Last update: April 8, 2026Executive profile
Josh was Chief Executive Officer at Lilly Oncology, and Operating Partner at Aisling Capital.
Josh Bilenker is currentlyChief Executive Officer at Treeline Biosciences - View - Treeline Biosciences org chart
Director at Sana Biotechnology - View - Sana Biotechnology org chart
Create your alert
to follow the career of Josh Bilenker.
Education
Josh Bilenker has a Bachelor of Arts in English from Princeton University in 1994 and a Medical Doctorate from Johns Hopkins University School of Medicine in 1999.
They have also studied at Princeton University :
Find more alumni from Princeton University
They have also studied at Johns Hopkins University School of Medicine :
Find more alumni from Johns Hopkins University School of Medicine
More about Josh Bilenker
Do you need to know more about Josh Bilenker? More results.
Participate
Social media
- Josh Bilenker on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Josh Bilenker
The colleagues of Josh Bilenker
Company Colleagues
- At Treeline Biosciences, Josh Bilenker has 11 colleagues including Sara Shulman (Preclinical Operations), Teresa Lavoie (Legal & Intellectual Property)…
- At Sana Biotechnology, Josh Bilenker has 27 colleagues including Steve Harr (CEO & Director), Patrick Yang (Director)…
Industry Colleagues
- In the Biotechnology industry, Josh Bilenker has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Josh Bilenker.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Josh Bilenker.
